Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
1(25.0%)
Phase 3
1(25.0%)
4Total
N/A(2)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07169344Phase 2Recruiting

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

Role: collaborator

NCT06983639Not ApplicableRecruiting

Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance

Role: collaborator

NCT03568968Phase 3Completed

A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease

Role: collaborator

NCT06211907Not ApplicableRecruiting

Small Macular Holes Treated With Air

Role: collaborator

All 4 trials loaded